comparemela.com

Latest Breaking News On - Venture partners investment advisor - Page 1 : comparemela.com

Frazier Life Sciences Management L P Has $28 31 Million Holdings in Arcutis Biotherapeutics, Inc (NASDAQ:ARQT)

Frazier Life Sciences Management L.P. grew its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,764,232 shares of the company’s stock after buying an additional 80,000 shares during […]

Frazier Life Sciences Management L P Has $28 31 Million Holdings in Arcutis Biotherapeutics, Inc (NASDAQ:ARQT)

Frazier Life Sciences Management L.P. grew its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,764,232 shares of the company’s stock after buying an additional 80,000 shares during […]

Gracell Biotechnologies Inc (NASDAQ:GRCL) Given Consensus Recommendation of Hold by Brokerages

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report) has received an average recommendation of “Hold” from the eight brokerages that are presently covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among brokerages […]

FNY Investment Advisers LLC Invests $100,000 in Gracell Biotechnologies Inc (NASDAQ:GRCL)

FNY Investment Advisers LLC Invests $100,000 in Gracell Biotechnologies Inc (NASDAQ:GRCL)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Adage Capital Partners GP L L C Acquires New Holdings in Gracell Biotechnologies Inc (NASDAQ:GRCL)

Adage Capital Partners GP L.L.C. bought a new position in Gracell Biotechnologies Inc. (NASDAQ:GRCL – Free Report) in the 3rd quarter, HoldingsChannel reports. The fund bought 850,000 shares of the company’s stock, valued at approximately $2,448,000. Other institutional investors and hedge funds have also recently bought and sold shares of the company. Vivo Capital LLC […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.